Kiernan T. DeAngelis's most recent trade in Humacyte Inc was a trade of 99,576 Stock Options (right to buy) done . Disclosure was reported to the exchange on Aug. 26, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Humacyte Inc | Kiernan T. DeAngelis | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 99,576 | 99,576 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Kiernan T. DeAngelis | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 1,575 | 1,575 | - | - | Stock Options (right to buy) |